Bupropion Hydrochloride Extended Release is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Marlex Pharmaceuticals Inc. The primary component is Bupropion Hydrochloride.
| Product ID | 10135-703_92753c87-016a-4d43-9512-b8a76a825148 |
| NDC | 10135-703 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Bupropion Hydrochloride Extended Release |
| Generic Name | Bupropion Hydrochloride |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-07-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA211200 |
| Labeler Name | Marlex Pharmaceuticals Inc |
| Substance Name | BUPROPION HYDROCHLORIDE |
| Active Ingredient Strength | 150 mg/1 |
| Pharm Classes | Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-07-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 10135-704 | Bupropion Hydrochloride Extended Release | Bupropion Hydrochloride Extended Release |
| 10135-703 | Bupropion Hydrochloride Extended Release | Bupropion Hydrochloride Extended Release |
| 0115-5445 | Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE |
| 0115-6811 | Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE |
| 0185-0410 | Bupropion Hydrochloride | Bupropion Hydrochloride |
| 0185-0415 | Bupropion Hydrochloride | Bupropion Hydrochloride |
| 0185-1111 | Bupropion Hydrochloride | Bupropion Hydrochloride |
| 0173-0135 | WELLBUTRIN | bupropion hydrochloride |
| 0173-0722 | WELLBUTRIN | bupropion hydrochloride |
| 0173-0947 | WELLBUTRIN | bupropion hydrochloride |
| 0173-0556 | ZYBAN | bupropion hydrochloride |